These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 15039656)

  • 1. Pharmacokinetics of erythrocyte-bound daunorubicin in patients with acute leukemia.
    Skorokhod OA; Garmaeva TTs; Vitvitsky VM; Isaev VG; Parovichnikova EN; Savchenko VG; Ataullakhanov FI
    Med Sci Monit; 2004 Apr; 10(4):PI55-64. PubMed ID: 15039656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immobilized forms of daunorubicin in patients with acute leukemia].
    Isaev VG; Garmaeva TTs; Skorokhod AA; Parovichnikova EN; Tiurina NG; Kucher RA; Vitvitskiĭ VM; Ataullakhanov FI; Savchenko VG
    Ter Arkh; 1999; 71(10):32-7. PubMed ID: 10612171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of isolated mononuclear cells from patients with acute myeloid leukemia affects cellular accumulation and efflux of daunorubicin.
    Knaust E; Porwit-MacDonald A; Gruber A; Xu D; Peterson C
    Haematologica; 2000 Feb; 85(2):124-32. PubMed ID: 10681718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomal daunorubicin plasmatic and renal disposition in patients with acute leukemia.
    Pea F; Russo D; Michieli M; Baraldo M; Ermacora A; Damiani D; Baccarani M; Furlanut M
    Cancer Chemother Pharmacol; 2000; 46(4):279-86. PubMed ID: 11052625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher plasma but not intracellular concentrations after infusion with liposomal daunorubicin compared with conventional daunorubicin in adult acute myeloid leukemia.
    Löfgren C; Lehmann S; Jönsson-Videsäter K; Möllgård L; Linder O; Tidefelt U; Hassan M; Paul C
    Ther Drug Monit; 2007 Oct; 29(5):626-31. PubMed ID: 17898654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daunorubicin-induced cell kill with 1-hour versus 24-hour infusions: a randomized comparison in children with newly diagnosed acute lymphoblastic leukemia.
    Escherich G; Göbel U; Jorch N; Spaar HJ; Janka-Schaub GE
    Klin Padiatr; 2007; 219(3):134-8. PubMed ID: 17525906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of daunorubicin and daunorubicinol in infants with leukemia treated in the interfant 99 protocol.
    Hempel G; Relling MV; de Rossi G; Stary J; De Lorenzo P; Valsecchi MG; Barisone E; Boos J; Pieters R
    Pediatr Blood Cancer; 2010 Mar; 54(3):355-60. PubMed ID: 19731319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of aclarubicin and its metabolites in humans and their disposition in blood cells.
    Ando S; Nakamura T; Kagawa D; Ueda T; Nishimura T; Kubo A; Tsutani H; Sasada M; Uchino H
    Cancer Treat Rep; 1986 Jul; 70(7):835-41. PubMed ID: 3459574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detrimental effects of Daunorubicin and Doxorubicin on human erythrocytes in vitro].
    Skorokhod AA; Vitvitskiĭ VM; Kul'man RA; Ataullakhanov FI
    Vopr Onkol; 1999; 45(4):374-9. PubMed ID: 10532094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing dose intensity of anthracycline antibiotics improves outcome in patients with acute myelogenous leukemia.
    Novitzky N; Thomas V; Abrahams L; du Toit C; McDonald A
    Am J Hematol; 2004 Aug; 76(4):319-29. PubMed ID: 15282663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoerythrosomes, a new derivative of erythrocyte ghost II: identification of the mechanism of action.
    Moorjani M; Lejeune A; Gicquaud C; Lacroix J; Poyet P; Gaudreault RC
    Anticancer Res; 1996; 16(5A):2831-6. PubMed ID: 8917393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients.
    Camera A; Rinaldi CR; Palmieri S; Cantore N; Mele G; Mettivier V; Miraglia E; Mastrullo L; Grimaldi F; Luciano L; Guerriero A; Rotoli B; Ferrara F
    Ann Hematol; 2009 Feb; 88(2):151-8. PubMed ID: 18709502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, postremission comparison of four courses of standard-dose consolidation therapy without maintenance therapy versus three courses of standard-dose consolidation with maintenance therapy in adults with acute myeloid leukemia: the Japan Adult Leukemia Study Group AML 97 Study.
    Miyawaki S; Sakamaki H; Ohtake S; Emi N; Yagasaki F; Mitani K; Matsuda S; Kishimoto Y; Miyazaki Y; Asou N; Matsushima T; Takahashi M; Ogawa Y; Honda S; Ohno R;
    Cancer; 2005 Dec; 104(12):2726-34. PubMed ID: 16284985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endotoxin binding to erythrocyte membrane and erythrocyte deformability in human sepsis and in vitro.
    Pöschl JM; Leray C; Ruef P; Cazenave JP; Linderkamp O
    Crit Care Med; 2003 Mar; 31(3):924-8. PubMed ID: 12627006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin prevents lipid peroxidation in human erythrocytes but augments deterioration of deformability after in vitro oxidative stress.
    Dikmenoglu N; Ileri E; Seringec N; Ercil D
    Clin Hemorheol Microcirc; 2008; 40(3):235-42. PubMed ID: 19029647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythrocyte membrane-bound daunorubicin as a delivery system in anticancer treatment.
    Gaudreault RC; Bellemare B; Lacroix J
    Anticancer Res; 1989; 9(4):1201-5. PubMed ID: 2817803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rheological characteristics of erythrocytes incubated in glucose media.
    Shin S; Ku YH; Suh JS; Singh M
    Clin Hemorheol Microcirc; 2008; 38(3):153-61. PubMed ID: 18239257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of liposomal daunorubicin (DaunoXome) during a phase I-II study in children with relapsed acute lymphoblastic leukaemia.
    Bellott R; Auvrignon A; Leblanc T; Pérel Y; Gandemer V; Bertrand Y; Méchinaud F; Bellenger P; Vernois J; Leverger G; Baruchel A; Robert J
    Cancer Chemother Pharmacol; 2001; 47(1):15-21. PubMed ID: 11221955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiotoxicity of daunorubicin and aclacinomycin A in patients with acute leukemia].
    Haruyama H; Shimazaki C; Nakanishi S; Hamami T; Nisio A; Isemura T; Katsume H; Nakagawa M; Ijichi H
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):516-21. PubMed ID: 6964037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.